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Parkinson diseaseLoss-of-function mutations in PINK1 or parkin genes are associated with juvenile-onset autosomal recessive
forms of Parkinson disease. Numerous studies have established that PINK1 and parkin participate in a com-
mon mitochondrial-quality control pathway, promoting the selective degradation of dysfunctional mito-
chondria by mitophagy. Upregulation of parkin mRNA and protein levels has been proposed as protective
mechanism against mitochondrial and endoplasmic reticulum (ER) stress. To better understand how parkin
could exert protective function we considered the possibility that it could modulate the ER–mitochondria
inter-organelles cross talk. To verify this hypothesis we investigated the effects of parkin overexpression
on ER–mitochondria crosstalk with respect to the regulation of two key cellular parameters: Ca2+ homeosta-
sis and ATP production. Our results indicate that parkin overexpression in model cells physically and func-
tionally enhanced ER–mitochondria coupling, favored Ca2+ transfer from the ER to the mitochondria
following cells stimulation with an 1,4,5 inositol trisphosphate (InsP3) generating agonist and increased
the agonist-induced ATP production. The overexpression of a parkin mutant lacking the ﬁrst 79 residues
(ΔUbl) failed to enhance the mitochondrial Ca2+ transients, thus highlighting the importance of the
N-terminal ubiquitin like domain for the observed phenotype. siRNA-mediated parkin silencing caused mito-
chondrial fragmentation, impaired mitochondrial Ca2+ handling and reduced the ER–mitochondria tether-
ing. These data support a novel role for parkin in the regulation of mitochondrial homeostasis, Ca2+
signaling and energy metabolism under physiological conditions.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Mitochondrial dysfunction and endoplasmic reticulum (ER) stress
contribute to the pathogenesis of Parkinson disease (PD) [1,2]. Al-
though PD is mostly idiopathic, our understanding of the molecular
mechanisms that lead to this pathology has dramatically improved
after the discovery of rare familial forms of PD, mainly associated to
mutations in leucine-rich repeat kinase 2 (LRRK2), α-synuclein,
DJ-1, PINK1 and parkin genes, being mutations in parkin gene respon-
sible for the 50% of autosomal recessive PD cases.
It is now well established that PINK1 and parkin participate in mi-
tochondrial quality control: PINK1 accumulation at the outer mito-
chondrial membrane of dysfunctional mitochondria recruits parkin,
which in turn promotes their selective degradation by mitophagy
[3–6].Biomedicine and Food Science,
, Italy. Tel.: +39 049 8276150;
rights reserved.Parkin is a cytosolic E3 ubiquitin ligase [7], that mediates
ubiquitylation of several targeted proteins through both classical
K48-linked polyubiquitin chains associated with the ubiquitin-
proteasome system (UPS) [8] andnon-classical K63-linked polyubiquitin
chains associated with the activation of the autophagic machinery [9],
thus underlining a dual role for parkin-mediated ubiquitination and a
functional link between UPS and autophagy [10,11]. Several outer
mitochondrial membrane proteins are ubiquitinated by parkin,
among them the voltage dependent anion channel VDAC1 [10,12],
mitofusins [10,13–15], Drp1 [16], Bcl-2 [17] and, more recently,
Bax ubiquitination by parkin has been demonstrated to prevent
Bax translocation to mitochondria and possibly apoptosis induction
[18].
Parkinhas been found cytoprotective indifferent conditions [19–26],
butwhether parkin could have a role onmitochondria under physiolog-
ical conditions, i.e., in the absence of their damage, is instead less clear.
Interestingly, parkin becomes transcriptionally upregulated during con-
ditions that inducemitochondrial and ER stress, and its downregulation
increased the vulnerability of cells to ER stress-induced mitochondrial
dysfunctions [27]. Accordingly, exogenous parkin overexpression was
protective against mitochondrial fragmentation and cell death induced
by thapsigargin and tunicamycin treatment. Notably, it has been shown
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and that it speciﬁcally prevented mitochondrial damage and cell death
without decreasing the level of ER stress, thus suggesting a functional
link between parkin, ER and mitochondria [27]. Mitochondria play a
central role in cell biology both as ATP producers and as regulators of
Ca2+ signal. ER physically and functionally interacts withmitochondria
to inﬂuence cellular physiology and viability, and the ER–mitochondria
close relationship is essential to guarantee ER–mitochondrial Ca2+
transfer and bioenergetics [28,29].
Disrupted ER–mitochondria communication with consequent
deregulation of Ca2+ homeostasis has been linkedwith the pathogene-
sis of several neurodegenerative diseases [30,31], including PD [32–34].
Thus, since ER-mitochondria interaction represents a privileged
communication in the modulation of Ca2+ ﬂuxes, we decided to in-
vestigate whether parkin could play a role in this relationship and
in the control of mitochondrial-related activities such as ATP synthe-
sis. Parkin was overexpressed in HeLa or neuroblastoma SH-SY5Y
cells together with the selectively targeted recombinant probe
aequorin or luciferase to monitor Ca2+ ﬂuxes or ATP production, re-
spectively [35,36]. We have found that parkin overexpression en-
hanced mitochondrial Ca2+ transients generated by cell stimulation
with a Ca2+ mobilizing agonist. Its overexpression also enhanced
ATP production following cell stimulation, thus supporting a role for
parkin in energy maintenance. We explored different possibilities to
explain these effects and we have found that parkin overexpression
favored ER–mitochondria tethering, thus indicating an important func-
tional role for parkin in ER–mitochondria communication. Our data
also suggest that the N-terminal ubiquitin-like domain is required
to mediated the observed phenotypes since the overexpression of a
ΔUbl parkin mutant failed to enhance mitochondrial Ca2+ transients.
Furthermore, our data revealed that proper ER–mitochondria commu-
nication is essential to sustainmitochondrial integrity and propermito-
chondrial Ca2+ handling under physiological conditions, since siRNA
mediated parkin down regulation severely compromised these param-
eters in SH-SY5Y cells.
2. Materials and methods
2.1. DNA constructs, antibodies, cell cultures and transfection
Human parkin full-length cDNA was cloned from a human brain
cDNA library (Clontech, Palo Alto-CA, USA) by PCR. The following
primers were used to amplify the cDNA: forward, 5′ CTG GCTAG
CATGATAGTGTTTGTCAGGTTCAAC- 3′ and reverse, 5′ CCGAATTCCC
TGGCTAC ACGTCGAACCAGTG-3′. The PCR product was cleaved by
NheI and EcoRI and cloned in pEGFP-C1 plasmid removing EGFP cDNA
(Clontech) to obtain parkin expression plasmid. ΔUbl parkin mutant
was obtained by amplifying wt parkin by PCR using the following
primers: forward 5′-GAAGTTCGAATTCATGAATGCAACTGGAGGCGACG
ACCCC-3′ and reverse 5′-ACTTCTCATCTAGACTACACGTCGAACCAGTGG
TCCCCC-3′. All the constructs were controlled by sequencing. Plasmids
encoding recombinant targeted aequorin probes and luciferase were
previously described [35,36].
Mouse monoclonal anti-parkin antibody (sc-32282, Santa Cruz
Biotechnology, Inc.) was used at 1:50 dilution in immunocytochemis-
try analysis and at 1:750 dilution in Western blotting analysis. Rabbit
polyclonal anti-HA1 (Cat. H6908 Sigma) was used at 1:100 dilution in
immunocytochemistry analysis. Mouse monoclonal anti-β-actin (AC-15,
Sigma)was used at 1:90,000 dilution; rabbit polyclonal anti-VDAC1 an-
tibody (PAB1231, Abnova) was used at 1:2000; mouse monoclonal
anti-α-tubulin (Cat. T6074 clone B-5-1-2, Sigma) was used at 1:1000
and rabbit polyclonal anti-mitofusin2 (AB50832, Abcam) was used at
1:1000 in Western blotting analysis.
HeLa cells and SH-SY5Y neuroblastoma cells were grown in
Dulbecco's modiﬁed Eagle's mediumHigh Glucose (DMEM, Euroclone),
supplemented with 10% fetal bovine serum (FBS, Euroclone), 100 U/mlpenicillin and 100 μg/ml streptomycin; 12 hours before transfection,
cells were seeded onto 13 mm (for Ca2+ and ATP measurements) or
24 mm (for TMRM and ER–mitochondria contact sites analysis) glass
coverslips and allowed to grow to 60–80% conﬂuence. For Ca2+, ATP
and TMRMmeasurements HeLa cells were co-transfectedwith aequorin,
luciferase and GFP constructs respectively and empty pcDNA3 vector
(mock) or parkin expressing plasmids in a 1:2 ratio with the calcium-
phosphate procedure as previously described [37]. SH-SY5Yneuroblasto-
ma cells were transfected by using the Attractene reagent (Qiagen)
according to the manufacturer's instructions. Ca2+ and ATP measure-
ments were performed 36 h later. Cells plated for Western blotting
were collected 24–36 h after transfection.
2.2. Immunocytochemistry analysis
Transfected HeLa or SH-SY5Y cells plated on coverslips were ﬁxed
with 3.7% formaldehyde in phosphate-buffered saline (PBS; 140 mM
NaCl, 2 mM KCl, 1.5 mM KH2PO4, 8 mM Na2HPO4, pH 7.4) for 20 min
or 3 min, respectively, and washed three times with PBS. Where indi-
cated, before ﬁxing, the cells were incubated with 10 μM CCCP in
DMEM for two hours in CO2 cell incubator, an equal volume of DMSO
was added to control cells. Cell permeabilization was performed by
20 min incubation in 0.1% Triton X-100/PBS, followed by 30 min wash
in 1% gelatin (type IV, from bovine skin, Sigma) in PBS at room temper-
ature. The coverslips were then incubated for 90 min at 37 °C in a wet
chamber with the speciﬁc antibody diluted in PBS. Staining was re-
vealed by the incubation with speciﬁc AlexaFluor 488 or AlexaFluor
594 secondary antibodies for 45 min at room temperature (1:100 di-
lution in PBS; Invitrogen). Fluorescence was analyzed with a Zeiss
Axiovert microscope equipped with a 12-bit digital cooled camera
(Micromax-1300Y; Princeton Instruments Inc., Trenton, NJ) or Leica
Confocal SP5 microscope. Images were acquired by using Axiovision
3.1 or Leica AS software.
2.3. Western blotting analysis
Where indicated, before proceeding with the preparation of cell
extracts, the cells were incubated with 10 μM CCCP in DMEM for
2 hours in CO2 cell incubator and an equal volume of DMSO was
added to untreated control cells.
HeLa and SH-SY5Y cells were ﬂooded, on ice, with 20 mM ice-cold
N-ethylmaleimide in PBS to prevent post-lysis oxidation of free cysteines.
Cell extracts were prepared by solubilizing cells in ice-cold lysis buffer
(150 mM NaCl, 50 mM Tris/HCl, 1 mM EGTA/Tris, 1% Triton, pH 7.4)
containing N-ethylmaleimide, 1 mM PMSF and cocktail protease inhibi-
tors (Sigma). Postnuclear supernatants were collected after 10 min
centrifugation at 10,000g at 4 °C. The total protein content was
determined by the Bradford assay (Biorad). Samples were loaded
on a 10% SDS-PAGE Tris/HCl gel, transferred onto PVDF membrane
(Biorad) and incubated overnight with the speciﬁc primary antibody
diluted in TBS-T (Tris Buffered Saline-Tween, 20 mM Tris, 0.137 M
NaCl, pH 7.6, 0.1 % Tween 20) at 4 °C after 1 h of blocking in 5 %
milk in TBS-T. Detection was carried out by incubation with second-
ary horseradish peroxidase-conjugated anti-mouse IgG antibody
(Santa Cruz Biotechnology) for 2 h at room temperature followed
by incubation with the chemiluminescent reagent Immobilon Western
(Millipore). Densitometric analyses were performed by using Kodak1D
image analysis software (Kodak Scientiﬁc Imaging Systems, New Haven,
CT). Means of densitometric measurements of at least three independent
experiments, normalized by the endogenous β-actin values, were com-
pared by Student's t test.
2.4. Subcellular fractionation
Preparation of mitochondrial fraction from HeLa cells: all samples
were maintained in ice and all centrifugations were performed at
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Then, the cells were re-suspended in HEPES buffer (10 mM HEPES,
0.25 M sucrose, pH 7.4, protease inhibitor cocktail was added at
time of use) and mechanically lysed using potter. Samples were
centrifuged at 1000g for 4 min to eliminate nuclei. Post nuclear su-
pernatant (PNS) was centrifuged at 1000g for 6 min to separate mito-
chondria from cytosolic fraction. The supernatant was centrifuged
three times and carefully collected without perturbing the bottom
of the tube. Mitochondria were washed three times with 500 μl
HEPES buffer and re-suspended in TES buffer (10 mM TES, 0.5%
NP40, pH 7.4, protease inhibitor cocktail was added at time of use).
2.5. Aequorin measurements
Mitochondrial low-afﬁnity aequorin (mtAEQ) and cytosolic wt
aequorin (cytAEQ) were reconstituted by incubating cells for 3 h
(cytAEQ) or 1.5 h (mtAEQ) with 5 μMwt coelenterazine (Invitrogen)
in DMEM supplemented with 1% fetal bovine serum at 37 °C in a 5%
CO2 atmosphere. To functional reconstitute low afﬁnity ER targeted
aequorin (erAEQ), the ER Ca2+ content had to be drastically reduced.
To this end, cells were incubated for 1.5 h at 4 °C in Krebs Ringer
modiﬁed buffer (KRB, 125 mM NaCl, 5 mM KCl, 1 mM Na3PO4, 1 mM
MgSO4, 5.5 mM glucose, 20 mM HEPES, pH 7.4, 37 °C), supplemented
with the Ca2+ ionophore ionomycin (5 μM), 600 μM EGTA and 5 μM
coelenterazine n (Invitrogen). Cells were then extensively washed
with KRB supplemented with 2% bovine serum albumin and 1 mM
EGTA [35]. After reconstitution cells were transferred to the chamber
of a purpose-built luminometer and Ca2+ measurements were started
in KRB medium added with 1 mM CaCl2 or 100 μM EGTA according
the different protocols and aequorin probes. 100 μM histamine in
HeLa cells or 100 nM bradykinin (BK) were added as speciﬁed in the
Figure legends. For mitochondrial Ca2+measurements in permeabilized
cells, after reconstitution, cells were transferred in an intracellular buffer
(IB) (130 mM KCl, 10 mM NaCl, 0.5 mM KH2PO4, 1 mM MgSO4, 5 mM
sodium succinate, 3 mM MgCl2, 20 mM HEPES, 5.5 mM glucose, 1 mM
pyruvic acid supplemented with 2 mM EGTA and 2 mM HEDTA,
pH 7.0) and then permeabilized in the same buffer supplemented
with 25 μM digitonin for 1 min. Cells were then perfused with
IB/EGTA containing 1 mM ATP (IB/EGTA-ATP) and transferred to
the luminometer chamber. Ca2+ uptake into mitochondria was
initiated by replacing IB/EGTA-ATP buffer with IB containing a 2 mM
EGTA-HEDTA-buffered Ca2+ of 1 μM, prepared as elsewhere described
[38,39].
All the experiments were terminated by cell lysis with 100 μM
digitonin in a hypotonic Ca2+-rich solution (10 mM CaCl2 in H2O)
to discharge the remaining reconstituted active aequorin pool. The
light signal was collected and calibrated off-line into Ca2+ concentra-
tion values, using a computer algorithm based on the Ca2+ response
curve of wt and mutant aequorin as previously described [40,41].
2.6. TMRM analysis
The TMRM “non-quenching”methodwas used,which is adequate for
the comparison of the membrane potential between two populations of
cells [42], and thus a decrease in TMRM signal reﬂected mitochondrial
depolarization. HeLa cells seeded on coverslip were co-transfected
with parkin expressing plasmid and cytosolic-GFP as a marker of
co-transfection, 30 h after transfection, cells were loaded with
20 nM TMRM for 30 min at 37 °C in KRB containing 1 mM CaCl2
and 5.5 mM glucose. TMRM ﬂuorescence was registered at the
wavelength of 510 nm with a Leica SP2 confocal microscope at
40× magniﬁcation. The normalized TMRM ﬂuorescence intensity was
obtained by acquiring images before and after application of proton ion-
ophore FCCP (10 μM) to redistribute TMRM away from mitochondria.
Measurements were corrected for residual TMRM ﬂuorescence after full
Δψmit collapse with FCCP. Basal average TMRM signal was normalizedto the average remaining signal obtained upon FCCP treatment. Regions
of interest (ROIs) were off-line positioned across the peripheral cell
area; TMRM ﬂuorescence was analyzed using ImageJ software.
2.7. ER–mitochondria contact sites and mitochondrial network integrity
analysis
HeLa and SH-SY5Y cells plated on 24 mm diameter coverslips
were transfected with erGFP and mtRFP together with empty or
parkin expressing vectors or with parkin siRNA 10 or Scr siRNA. Fluo-
rescence was analyzed in living cells by Leica SP2 confocal micro-
scope. Cells were excited separately at 488 nm or 543 nm, and the
single images were recorded. Confocal stacks were acquired every
0.2 μm along the z-axis (for a total of 30–40 images) with a 63× ob-
jective. Cells were maintained in KRB containing 1 mM CaCl2 and
5.5 mM glucose during acquisition of images. For mitochondria–ER
interaction analysis, stacks were automatically thresholded using
ImageJ, deconvoluted, 3D reconstructed and surface rendered by
using VolumeJ (ImageJ). Interactions were quantiﬁed by Manders'
colocalization coefﬁcient as already described [43,44]. Mitochondrial
circularity, perimeter and area, are calculated as described elsewhere
[45].
2.8. Luciferase assays
Luciferase luminescence was measured as previously published [36].
HeLa cells co-transfectedwith a cytosolic or mitochondrial luciferase chi-
mera (cytLuc or mtLuc) were perfused at 37 °C with KRB containing
20 μM luciferin and 1 mM CaCl2 and supplemented with either 5.5 mM
glucose. Where indicated, the agonist histamine (100 μM) was added to
the perfusion medium to evoke cellular response. The light output of a
coverslip of transiently transfected cells was 500–5000 cps versus a back-
ground output of less than 10 cps.
2.9. siRNA mediated knockdown
SH-SY5Y cells were transfected with two different validated
pre-designed siRNA oligonucleotides (Qiagen) directed against human
parkin (Hs_PARK2_9 siRNA, SI04240397 and Hs_PARK2_10 siRNA,
SI04246550) using the Attractene reagent (Qiagen), which is also high-
ly suitable for co-transfection of plasmid DNA with siRNA. The siRNA
transfection protocol was adjusted according to the manufacturer's in-
structions (12–18 pmol of each siRNA oligo were added for each 2 μl
of Attractene). RNAi negative control duplex, i.e., scramble siRNA,
(which sequencematched no knownmRNA sequence in the vertebrate
genome) was purchased from Qiagen (AllStars Neg. siRNA AF 488,
1027284). Brieﬂy, the day before the experiment the cells were seeded
at 70–80% conﬂuence in a 24-well plate in 500 μl of culture medium
containing serum and antibiotics. The day after, transfection complexes
were added drop-wise, and incubated under normal growth conditions.
Gene down regulation and mitochondrial Ca2+ transients were moni-
tored 36–48 h after transfection.
2.10. Statistical analysis
Data are reported as means±S.E.M. Statistical differences were
evaluated by Student's two-tailed t test for impaired samples, with
p value 0.05 being considered statistically signiﬁcant.
3. Results
3.1. Parkin overexpression selectively enhanced mitochondrial Ca2+
transients in agonist-stimulated HeLa cells
To understandwhether increased parkin expression couldmodulate
the ER–mitochondria interplay, we ﬁrst analyzed Ca2+ homeostasis in
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endogenous parkin [3,46] and thus represent a good model to speciﬁ-
cally study the effect of parkin exogenous expression. In parallel to
the overexpression of wt parkin we also analyzed the overexpression
of a parkin mutant missing the ﬁrst 79 amino acids, which represent
the ubiquitin-like (Ubl) domain [47]. By using a well characterized
anti-parkin antibody (PRK8) [5,48], we found that endogenous parkin
was not detectable by Western blotting analysis in empty vector
transfected HeLa cells, while exogenously introduced wt parkin was
detected as a doublet with a strong immunoreactive band at ~50 kDa
and aweaker fastermigrating band at ~40 kDa (Fig. 1A), possibly corre-
sponding to a smaller parkin species originated from an internal start
site and lacking the N-terminal Ubl domain, as previously reported
[47,48]. The N-terminally truncated parkin mutant showed exactly the
same size on SDS-PAGE as the smaller parkin species generated after
the expression of wt parkin. An additional band of about 38 kDa was
also present in both cases corresponding to a previously describedFig. 1.Western blotting analysis and immunolocalization of exogenously overexpressed wt p
mutant expression plasmids and analyzed by Western blotting (A) or immunocytochemistr
or ΔUbl parkin mutant and mtRFP to label mitochondria. (C) Western blotting analysis aft
with 10 μM CCCP for 2 hours. Mitofusin 2 (Mfn2) and voltage anion channel 1 (VDAC1) wer
fraction (Cyt). PNS, post nuclear supernatant (see Materials and methods).species generated by proteolytic cleavage [47]. Equal loading of proteins
was veriﬁed by probing the membrane with an anti β-actin antibody.
Immunocytochemistry analysis revealed that, under steady-state condi-
tions, wt and ΔUbl parkin mutant were diffusely localized throughout
the cytosol with no nuclear exclusion (Fig. 1B). Treatment with the
mitochondrial uncoupler CCCPwas performed to induce parkin translo-
cation to mitochondria (which were labeled by co-transfection with
mitochondria-targeted red ﬂuorescent protein encoding plasmid,
mtRFP). Both wt parkin and, even if to a less extent, ΔUbl parkin mu-
tant were able to translocate. To better characterize the intracellular
distribution of our overexpressedwt andmutant parkin, subcellular frac-
tionation experiments were performed in control and CCCP treated cells
(Fig. 1C). Western blot analysis revealed that overexpressed wt andmu-
tant parkinweremainly located in the cytosolic fraction but, interesting-
ly, a detectable amount was also found in the mitochondrial fraction
under steady state conditions in the absence of CCCP treatment (left
half of the panels). CCCP treatment induced a massive translocation ofarkin or ΔUbl parkin mutant. HeLa cells were transfected with wt parkin or ΔUbl parkin
y (B). For the immunocytochemistry analysis, cells were co-transfected with wt parkin
er subcellular fractionation. Where indicated the different cell batches were incubated
e used as positive controls for mitochondria fraction (Mito), α-tubulin for the cytosolic
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data shown by immunocytochemistry analysis. Mitochondrial transloca-
tion was also appreciated for the parkin mutant, even if less pronounced
in respect to wt parkin, suggesting that the deletion of the Ubl domain
impaired (but did not abolish) the translocation of parkin to mitochon-
dria under depolarization conditions. Mitofusin 2 (Mfn2), the outer
mitochondrial membrane voltage gated anion channel VDAC1 and
α-tubulin were used as markers for the mitochondrial and the cytosolic
fractions, respectively.
Once established that exogenous parkin was properly expressed, lo-
calized, and translocated tomitochondria upon depolarization, intracel-
lular Ca2+ homeostasis was analyzed using aequorin probes targeted to
the mitochondrial matrix (mtAEQ), to the cytosol (cytAEQ) or to the
lumen of the ER (erAEQ) [35]. To conﬁrm parkin coexpression with
aequorin probe, double immunostaining was performed for parkin-
mtAEQ co-transfected cells: Fig. 2A shows that parkin positive cells
were also positive for mtAEQ. Statistical analysis and representative
traces of typical Ca2+ measurements are shown in Fig. 2B–D. Where
indicated, cells were exposed to 100 μM histamine (His), causing the
generation of inositol 1,4,5 trisphosphate (InsP3) and the consequent
opening of the InsP3 channels of the intracellular stores. Mitochondrial
Ca2+ transients in wt parkin overexpressing cells were signiﬁcantly
higher than those observed in empty vector transfected cells, but
the overexpression of ΔUbl parkin mutant failed to enhance them
(Fig. 2B, peak values: 105.01±3.80 μM in control HeLa cells, n=24Fig. 2. Ca2+ measurements in wt parkin or ΔUbl parkin mutant overexpressing HeLa cells.
anti-parkin antibody and an anti-HA1 antibody were used to reveal the co-expression of pa
(C) and ER (D) Ca2+ concentration were measured by transfecting mtAEQ, cytAEQ or erAEQ
cated. Where indicated 100 μM histamine (His), an InsP3 generating agonist, was applied
⁎⁎⁎pb0.0001. The traces are representative of a typical experiment out of at least 14 ind
lumen (Means±SEM) and the kinetics of ER reﬁlling upon re-addition of CaCl2 1 mM to
least 9 independent experiments.vs. 132,01±4.55 μM in wt parkin overexpressing HeLa cells, n=23,
pb0.0001 or vs. 104.44±4.22 in ΔUbl parkin mutant overexpressing
HeLa cells, n=14). To analyze the possibility that the enhanced mito-
chondrial Ca2+ uptake in wt parkin overexpressing cells was depen-
dent on wt parkin action on organelles other than mitochondria, thus
playing a more general role in Ca2+ homeostasis, Ca2+ concentration
was also monitored in the cytosolic compartment and in the lumen of
the ER using speciﬁcally targeted aequorin probes. Cytosolic Ca2+ tran-
sients upon agonist-stimulation did not signiﬁcantly differ in wt parkin
overexpressing and control cells (Fig. 2C, cytosolic peak values: 3.19±
0.08 μM in vector transfected control cells, n=17 vs. 3.27±0.08 μM
in wt parkin overexpressing HeLa cells, n=14;). Similarly, ER Ca2+
levels were unaffected by wt parkin overexpression (Fig. 1D, ER Ca2+
levels: 282.5±14.48 μM in control cells, n=9 vs. 298.4±21.78 μM in
wt parkin overexpressing HeLa cells), highlighting the possibility that
wt parkin may speciﬁcally interfere withmitochondrial Ca2+ handling.
3.2. Mitochondrial Ca2+ uptake machinery was not modiﬁed by parkin
overexpression
Mitochondrial Ca2+ transport into the matrix depends on the pro-
ton electrochemical gradient that drives rapid accumulation of cations
across the mitochondrial inner membrane and on the mitochondrial
Ca2+ uniporter (MCU, [49,50]) that, upon cell stimulation, is exposed
to microdomains of high Ca2+ concentration. These microdomains(A) Double immunocytochemistry analysis of mtAEQ/wt parkin coexpressing cells. An
rkin and HA-tagged mitochondrial aequorin, respectively. Mitochondrial (B), cytosolic
(control) or co-transfecting them with wt parkin or ΔUbl parkin mutant, where indi-
. In (B) and (C) bars represent mean [Ca2+] values upon stimulation. Means±SEM,
ependent experiments. Panel (D) shows the average plateau Ca2+ values in the ER
Ca2+-depleted cells (see Materials and methods). The traces are representative of at
Fig. 3. Mitochondrial Ca2+ uptake in permeabilized cells and mitochondrial membrane
potential in parkin overexpressing HeLa cells. (A) Representative traces (left) and average
plateau [Ca2+]m values (right, Means±SEM) reached in permeabilized cells exposed to
1 μM Ca2+-buffered solution. Where indicated, the medium was switched from IB/
EGTA-ATP to IB/1 μMCa2+. The traces are representative of at least 10 independent exper-
iments. (B) Immunocytochemistry analysis on permeabilized HeLa cells overexpressing
parkin. The stainingwithmonoclonal antibody against parkinwas revealed by AlexaFluor
488 conjugated antibody. (C) HeLa cells (control and overexpressing parkin) were loaded
with TMRM probe to determine themitochondrial membrane potential (ΔΨ). Bars repre-
sent the average TMRM ﬂuorescence signals subtracted of signals remaining after FCCP
treatment to collapseΔΨ, and expressed as % Δ ﬂuorescence (Means±SEM). The analysis
was performed on n=124mock cells and on n=264 parkin overexpressing cells, 3 inde-
pendent experiments, ⁎pb0.05.
500 T. Calì et al. / Biochimica et Biophysica Acta 1832 (2013) 495–508well match its low Ca2+ afﬁnity and are sensed thanks to the close con-
tact of mitochondria with ER Ca2+ channels [51], suggesting that ER–
mitochondria tethering is an essential element in the control of mito-
chondrial Ca2+ ﬂuxes. To investigatewhether the overexpressed parkin
could directly interfere with the mitochondrial Ca2+ transport machin-
ery, mitochondrial Ca2+ uptake in parkin overexpressing cells was in-
vestigated in permeabilized cells exposed to ﬁxed Ca2+ concentration
solution (representative traces of a typical experiment and statistical
analysis are shown in Fig. 3A). Brieﬂy, control and parkin overexpressing
HeLa cells were perfused with a solution mimicking the intracellular
milieu (IB), supplemented with 2 mM EGTA, and permeabilized with
25 μM digitonin for 1 min (for details see Materials and methods).Fig. 4. Evaluation of the contribution of ER Ca2+ mobilization and of Ca2+ inﬂux from the
overexpressing cells. (A) HeLa cells were co-transfected with mtAEQ and parkin constru
[Ca2+]m transients, InsP3-induced Ca2+ release from intracellular stores was separated from
in KRB/EGTA 100 μM buffer and stimulated with histamine to release Ca2+ from the intrace
(in the continuous presence of histamine) to stimulate Ca2+ entry from the extracellular am
Bars represent normalized mean [Ca2+] values upon stimulation, Means±SEM. ⁎⁎⁎pb0.0
transfected with mtRFP/erGFP only (mock). Single plane images and three-dimensional rec
or in controls as indicated in each panel. Cells were excited separately at 488 nm or 543 nm,
condition. Yellow indicates colocalization of the two organelles. Insets at higher magniﬁcat
total of 40 images) with a 63× objective. (C) Manders’ coefﬁcient for colocalization, ca
overexpressing cells and n=96 mock cells in 2 independent experiments (Means±SEM, ⁎Then, the perfusion buffer was changed to IB/EGTA-ATP-buffered Ca2+
of 1 μM eliciting a gradual rise in mitochondrial Ca2+ concentration
([Ca2+]m) that reached a plateau value of approximately 40 μM
(38.55±2.03 μM in vector transfected control cells, n=12 vs. 39.52±
1.99 μMinparkin overexpressing cells, n=10). In parkin overexpressing
HeLa cells, the [Ca2+]m increase was similar to that observed in empty
vector transfected controls. To exclude that the absence of effects
was due to the release of parkin after digitonin treatment, immunocyto-
chemistry analysis was performed on permeabilized cells and Fig. 3B
showed that the diffuse cytosolic parkin signal was still present as in
non-permeabilized cells. Then, mitochondrial membrane potential
ΔΨ was estimated by loading cells with the potential-sensitive
probe tetramethyl rhodamine methyl ester (TMRM) according the
protocols described in Material andmethods section. The data reported
in Fig. 3C were plotted as Δ% TMRM ﬂuorescence calculated by
subtracting theﬂuorescence values after FCCP treatment from the initial
ﬂuorescence values. In agreement with a previous report [52], the analy-
sis revealed a slight increase in the TMRM ﬂuorescence values in parkin
overexpressing cells with respect to controls (% Δ TMRM ﬂuorescence:
36.16±0.99 in vector transfected control cells, n=124 vs. 40.24±0.70
in parkin overexpressing cells, n=264, pb0.05) that is consistent with
amild increase in the driving force formitochondrial Ca2+ accumulation,
that however did not inﬂuence the intrinsic capacity of mitochondria to
take up Ca2+ in permeabilized cells as shown in Fig. 3A.
3.3. Parkin overexpression increased functional and physical
ER–mitochondria interactions
The experiments on parkin overexpressing permeabilized cells
(Fig. 3A) excluded a direct involvement of parkin in the modulation of
the activity of mitochondrial Ca2+ transporters. A possible explanation
for the action of parkin on mitochondrial Ca2+ homeostasis could
match with a role in the formation and/or the stabilization of ER–
mitochondria interactions. To verify this hypothesis at the functional
and structural level, we employed two different approaches (Fig. 4).
First, the contribution of the ER Ca2+ release and that of the extracellu-
lar Ca2+ entry to the mitochondrial Ca2+ transients generation were
analyzed separately. In these experiments, HeLa cells overexpressing
parkin were perfused in KRB containing 100 μM EGTA and stimulated
with 100 μM histamine: under these conditions a peak transient
was generated, reﬂecting themitochondrial response to ER Ca2+mo-
bilization. Then, the perfusion medium was switched to KRB
supplemented with 2 mM CaCl2 (in the continuous presence of
histamine) thus causing Ca2+ entry from the extracellular milieu that
was primarily sensed by mitochondria located beneath the plasma
membrane. Fig. 4A shows representative traces of a typical experiment
and statistical analysis of the peak transient heights. The mitochondrial
Ca2+ peak in response to ER Ca2+ mobilization (1st peak) was signiﬁ-
cantly higher in cells overexpressing parkin (peak values: 38.31±
2.39 μM, n=15) compared to vector transfected control cells (peak
value: 27.14±1.29 μM, n=25; pb0.0001). The Ca2+ peak generated
in response to Ca2+ inﬂux (2nd peak) was instead similar in both cell
batches (peak values: 7.37±0.49 μM, n=25 in vector transfected con-
trol cells vs. 6.42±0.96 μM, n=15 for parkin overexpressing cells).
Second, to directly test the possible involvement of parkin in regulatingextracellular ambient to [Ca2+]m and of the ER–mitochondria interactions in parkin
cts or transfected with mtAEQ only (control). To discriminate the contributions to
the concomitant Ca2+ inﬂux across the plasma membrane. HeLa cells were perfused
llular stores (1st peak). Then, the perfusion medium was switched to KRB/Ca2+ 2 mM
bient (2nd peak). The traces are representative of at least 15 independent experiments.
001. (B) HeLa cells were co-transfected with mtRFP/erGFP and parkin constructs or
onstruction of mitochondria (red) and ER (green) in HeLa cells overexpressing parkin
and the single images were recorded. The merging of the two images is shown for each
ion are also shown. Confocal stacks were acquired every 0.2 μm along the z-axis (for a
lculated from z-axis confocal stacks. The analysis was performed on n=81 parkin
⁎⁎pb0.0001).
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copy three-dimensional reconstructions of ER and mitochondria. HeLa
cells were co-transfected with mtRFP and the ER-targeted GFP (erGFP)
together with either parkin or empty vector and ER–mitochondria
co-localization was assessed. A detailed confocal microscopy analysiscarried out by acquiring 25 to 30 confocal z-axis stacks and applying vol-
ume rendering on the 3D reconstructions showed anenhancement in the
ER/mitochondria co-localization in parkin overexpressing cells compared
to vector transfected control cells. Fig. 4B shows representative images at
the single plane level and after rendering of the z-stacks. The area of
502 T. Calì et al. / Biochimica et Biophysica Acta 1832 (2013) 495–508co-localization of the two organelles is clearly appreciated in the merge
and inset panels. A quantiﬁcation of the area of co-localization was
obtained by calculating Manders' coefﬁcient [44] and revealed an in-
crease of about 10% in parkin overexpressing cells compared to vector ex-
pressing control cells (Fig. 4C, mock cells, 100±1.34%, n=96 and parkin
109.38±1.10%, n=81 cells, pb0.0001). Altogether, the data presented
so far indicated that parkin is able to enhance mitochondrial Ca2+ tran-
sients by potentiating the ER–mitochondria connections.
3.4. Parkin overexpression enhanced agonist-stimulated ATP production
To assess whether the favored ER–mitochondrial coupling, and the
consequent enhancement in mitochondrial Ca2+ transients could
have a role in energetic cellular balance, we monitored cytosolic
and mitochondrial ATP levels with speciﬁcally targeted luciferases
cytLuc and mtLuc [36] both in control and parkin overexpressing
cells. Brieﬂy, cells were perfused with KRB, supplemented with glu-
cose (5.5 mM) and 1 mM CaCl2 and then shifted to the same buffer
supplemented with 20 μM luciferin until a plateau was reached,
where indicated cells were challenged with histamine (100 μM) and
a second plateau is generated corresponding to the amount of
newly synthetized ATP. The data are represented as % of counts per
second (cps) normalized with respect to the ﬁrst plateau. Fig. 5A
showed that cytosolic ATP levels were signiﬁcantly enhanced in
parkin overexpressing cells as compared to control cells in responseFig. 5. Functional analysis of energetic metabolism in parkin overexpressing HeLa cells. Cytos
and mtLuc recombinant luciferase and after histamine stimulation. Data are expressed as pe
second. Data are typical of at least 8 independent experiments which gave the same resultto agonist stimulation, (128.48±1.22 %, n=8 in vector transfected cells
vs. 135.16±0.81 %, n=12 in parkin overexpressing cells, pb0.0001).
However, mtLuc probe failed to revealed differences in mitochondrial
ATP production between the two cell batches (Fig. 5B, 146.45±1.51 %,
n=20 in vector transfected cells and 145.10±1.70 %, n=13 in parkin
overexpressing cells).
These data indicate that parkin not only may have role in
guaranteeing homeostatic Ca2+ ﬂuxes from ER to mitochondria but
also in supporting ATP production.
3.5. siRNA-mediated parkin down-regulation caused mitochondrial
fragmentation, compromised mitochondrial Ca2+ transients and reduced
ER–mitochondria contact sites in human dopaminergic neuroblastoma
cells
To clarify whether the observed enhancement of ER–mitochondria
communication was a condition that had functional consequences
only after parkin overexpression, or may also have a constitutive
role inmaintaining ER–mitochondria functionswe decided to perform
siRNA-mediated parkin silencing in human dopaminergic SH-SY5Y
neuroblastoma cells, a cellular model harboring endogenous parkin
protein, albeit at low levels [12,21,53]. Before performing experiments
in parkin-silenced cells, the effects of parkin overexpression in
SH-SY5Y cells were tested. Figs. 6A and B show Western blotting and
immunocytochemistry analysis performed in control cells and inolic (A) and mitochondrial (B) ATP production was evaluated by co-transfecting cytLuc
rcent of cytLuc or mtLuc light output of cells before agonist stimulation. cps, counts per
s. Bars indicate Means±SEM, ⁎⁎⁎pb0.0001.
Fig. 6.Western blotting analysis, immunolocalization and Ca2+ measurements in parkin overexpressing SH-SY5Y cells. SH-SY5Y cells were transfected with parkin expression plas-
mid and analyzed by Western Blotting (A) or immunocytochemistry (B). mtRFP was co-transfected to visualize mitochondria and where indicated CCCP treatment was performed
to induce parkin translocation to mitochondria. Cells were transfected with mtAEQ, cytAEQ or erAEQ (control) or co-transfected with mtAEQ, cytAEQ or erAEQ and parkin. Mito-
chondrial (C), cytosolic (D) and ER (E) Ca2+ concentration in SH-SY5Y cells overexpressing parkin. Where indicated 100 nM bradykinin (BK), an InsP3 generating agonist, was ap-
plied. In (C) and (D) bars represent mean [Ca2+] values upon stimulation. Means±SEM, ⁎⁎pb0.001. The traces are representative of a typical experiment out of at least 3
independent experiments. Panel (E) shows the average plateau Ca2+ values in the ER lumen (Means±SEM) and the kinetics of ER reﬁlling upon re-addition of CaCl2 1 mM to
Ca2+-depleted cells (see Materials and methods). The traces are representative of at least 5 independent experiments.
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revealed the presence of a doublet at ~50 kDa and ~40 kDa, as
observed in transfected HeLa cells. Endogenous parkin was not visible,
possibly due to its very low level of expression and to the strong immu-
noreactivity of the overexpressed protein that could obscure its detec-
tion (see below). Immunocytochemistry analysis revealed a diffuse
cytosolic signal and, similarly to what observed for HeLa cells,
overexpressed parkin displayed the ability to translocate to mitochon-
dria upon CCCP treatment (Fig. 6B). Mitochondria, cytosolic and ER
Ca2+ levels were thus monitored in SH-SY5Y cells with speciﬁcally
targeted aequorins and the results are reported in Fig. 6C, D and E,
respectively.
Mitochondrial Ca2+ transients in parkin SH-SY5Y overexpressing
cells were signiﬁcantly higher than those measured in empty vectortransfected cells (Fig. 6C, peak values: 133.42±5.38 μM in parkin
overexpressing SH-SY5Y cells, n=6 vs 107.48±6.48 μM in control
cells, n=7, pb0.001).
Cytosolic Ca2+ transients upon agonist-stimulation and ER Ca2+
levels resulted not signiﬁcantly different in parkin overexpressing
and control cells (Fig. 6D, cytosolic peak values: 1.95±0.03 μM in
vector transfected control cells, n=3 vs. 1.78±0.04 μM in parkin
overexpressing SH-SY5Y cells, n=4; Fig. 6E, ER Ca2+ levels: 235±
10.38 μM in control cells, n=7 vs. 266±16.66 μM in parkin
overexpressing SH-SY5Y cells, n=5). These data indicated that the ef-
fects on mitochondrial Ca2+ homeostasis observed following parkin
overexpression were not cell type-speciﬁc and supported the evidence
that the modulation of mitochondrial Ca2+ homeostasis represents a
speciﬁc target of parkin action.
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blotting analysis of siRNA dose-dependent reduction of parkin expres-
sion level following incubation with different amount of two indepen-
dent validated parkin siRNA (siRNA 9 and siRNA 10). The quantiﬁcation
was carried out by densitometric analysis and the amounts parkin levels
are indicated by the numbers below the image as values normalizedwith
respect to the β-actin levels. In this case, endogenous parkin levels were
visible, even if it was necessary to overexpose the nitrocellulose mem-
brane to reveal it.
Once conﬁdent on the parkin siRNA efﬁciency, we performed 18
pmol siRNA treatments in SH-SY5Y control cells and analyzed theirFig. 7. Silencing of parkin in SH-SY5Y cells impairs mitochondrial morphology and Ca2+ tran
siRNA (scr siRNA) and parkin siRNA transfected SH-SY5Y cells. Two doses (12 pmol and 18 p
evaluate the siRNA efﬁciency. The numbers below the blotting refer to normalized parkin/β−
siRNA 10 or scr siRNA and mtRFP were co-transfected in SH-SY5Y cells. After 36–48 h cells,
The Panel displays representative mitochondrial phenotypes observed by monitoring mtRF
mitochondrial circularity (C), perimeter (D) and area (E), see [45] for details. The values
expressed as %. Means±SEM, *pb0.01, at least n=47 cells/conditions, three independent
siRNA 9 or parkin siRNA 10 or scramble siRNA SH-SY5Y treated cells; where indicated 10
The traces are representative of at least 7 independent experiments. Means±SEM, ⁎⁎pb0.0mitochondrial morphology by monitoring the ﬂuorescence signal of
the co-transfected mtRFP. The analysis of the mitochondrial network
integrity revealed that, when the scramble siRNA was applied, the
majority of the cells showed an intact network of tubular mitochon-
dria, but when the cells were incubated with parkin siRNA 9 or
siRNA 10 mitochondria lose their tubular morphology and appeared
truncated and fragmented, as shown in Fig. 7B and in agreement to
what previously reported in several different cell types [54,55]. A
quantitative analysis of the mitochondrial network integrity was
performed using the “Mito-Morphology” macro of the Image J soft-
ware [45]. The measure of mitochondrial morphological parameterssients. (A) Western blotting and quantiﬁcation of siRNA-mediated silencing in scramble
mol, respectively) of two different parkin siRNA (siRNA 9 and siRNA 10) were applied to
actin ratio±SEM obtained in 3 independent experiments. (B) Parkin siRNA 9 or parkin
were observed under ﬂuorescence microscope to evaluate mitochondrial morphology.
P ﬂuorescence. (C, D and E) Quantiﬁcation of mitochondrial morphology by calculating
were normalized with respect to the values calculated in scr siRNA treated cells and
experiments. (F) Mitochondrial Ca2+ transients induced by cell stimulation in parkin
0 nM bradykinin (BK) was applied. Bars indicate the average heights of peak values.
01, ⁎⁎⁎pb0.0001.
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(Fig. 7C) in both parkin siRNA treated cell batches and a concomitant
signiﬁcant decrease in the average perimeter and area of the single
objects analyzed (Figs. 7D and E, respectively). These results strongly
indicated that endogenous parkin was required to maintain the prop-
er mitochondrial tubular architecture. Mitochondrial Ca2+ measure-
ments were then performed. As shown in Fig. 7 F, parkin siRNA 9
and 10 but not scramble siRNA treatment affected the ability of mito-
chondria to take up Ca2+, being the mitochondrial peak height of
98.60±2.48 μM in scrambled siRNA control cells, n=21 vs. 78.71±
3.26 μM in parkin siRNA 9 treated cells, n=22, pb0.001 and
77.39±2.54 in parkin siRNA 10 treated cells, n=7, pb0.0001.
To prove that the decreased functional ER–mitochondria interac-
tion which resulted in the observed reduction of ER–mitochondria
Ca2+ transfer would be dependent on an impairment in the formation
of ER–mitochondria contact sites, we performed live-cell confocal mi-
croscopy three-dimensional reconstructions of ER and mitochondria in
SH-SY5Y cells treatedwith parkin siRNA 10. Fig. 8A shows representativeFig. 8. Effects of parkin silencing on the ER–mitochondria interactions in SH-SY5Y cells. (A)
Single plane images and three-dimensional reconstruction of mitochondria (red) and ER (
colocalization, calculated from z-axis confocal stacks. The analysis was performed on n=47
periments (Means±SEM, ⁎⁎⁎pb0.0001).images at the single plane level and after rendering of the z-stacks.
The area of co-localization of the two organelles is clearly appreciat-
ed in the merge and inset panels. A quantiﬁcation of the area of
co-localization was obtained by calculating Manders' coefﬁcient
[44] and revealed a decrease of about 10% in parkin siRNA compared
to control scr siRNA treated cells (Fig. 8B, scr siRNA treated cells,
100±1.40%, n=47 and parkin siRNA 10 treated cells 88.58±1.5%,
n=54 cells, pb0.0001).
4. Discussion
Recent research on PD-associated genes has contributed novel in-
sights of biochemical pathways related with the disease process. The
development of knock out animal models, even if failed to reproduce
the human neurodegenerative condition, had an enormous impor-
tance since in all cases it permitted to reveal mitochondrial dysfunc-
tion, thus reinforcing the idea that compromised mitochondria
physiology has a pivotal role in the pathogenesis of PD. In particular,SH-SY5Y cells were co-transfected with mtRFP/erGFP and scr siRNA or parkin siRNA10.
green) as indicated in each panel. Conditions as in Fig. 4. (B) Manders' coefﬁcient for
scr siRNA treated cells and n=54 parkin siRNA 10 treated cells in 2 independent ex-
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oxidative phosphorylation were reported in parkin-knockout mice,
which exhibited normal brain morphology, but increased striatal
extracellular dopamine levels [56]. Increased parkin levels were
associated with protection from cellular stress and cell cycle regulation
[57–59] and overexpression of parkin in cultured cells not only rescued
mitochondrial dysfunction caused by PINK1 loss of function, but exerted
a cytoprotective role against different toxic stressor [19–23,26]. Several
studies have elucidated the PINK1/parkin pathway, demonstrating that
PINK1 acted as sensor ofmitochondrial damage [60] necessary to specif-
ically recruit parkin on dysfunctionalmitochondria and to promote their
autophagic degradation [3–5,12]. If the action of parkin on damagedmi-
tochondria is well recognized, its role in physiological condition is still
obscure. The ﬁnding that, after ER stress induction, parkin gene was in-
duced and mitochondrial degeneration, which normally occurred in
these conditions, was prevented [27], suggested that parkin may also
have a cytoprotective role independently to its mitochondria transloca-
tion and consequent mitophagy activation. We searched for this role by
investigating the ER–mitochondria relationship in terms of Ca2+ signal-
ing, since Ca2+ dyshomeostasis and ER–mitochondria coupling play a
prominent role in neuronal cell death.
To date, only one study reported possible involvement of parkin in
Ca2+ homeostasis. In the study, parkin silenced cells and cells ex-
pressing parkin mutants displayed increased basal cytosolic Ca2+
levels and longer lasting responses following agonist stimulation.
These alterations in Ca2+ homeostasis were attributed to increased
levels of phospholipase Cγ1 in parkin knock out cells, and the possi-
bility that impaired ability of mitochondria to take up Ca2+ could par-
ticipate in compromising buffering capacity was excluded [21].
Our study demonstrated that parkin overexpression speciﬁcally in-
duced an increase in the mitochondrial Ca2+ transients evoked by cell
stimulation and that such increase was not observed by overexpressing
a parkin N-terminal truncation mutant lacking the Ubl domain,
suggesting that this domain is necessary to this parkin function. In-
terestingly, the entity of the transients was not only compatible
with physiological levels of mitochondrial Ca2+ concentration, but
also positively modulated ATP production thus sustaining cell bioen-
ergetics. Themechanism underlining enhanced cytosolic ATP levels are
presently unclear: it could bedependent on a secondary effect related to
increased ATP translocation from mitochondria to cytosol through the
ATP/ADP exchanger, possibly enhanced by the slight mitochondrial hy-
perpolarization [61] (accordingly to the increased TMRM ﬂuorescence)
in parkin overexpressing cells. The effect on mitochondrial membrane
potential was previously observed and it was attributed to enhanced
complex I levels and activity [52,62].
The rate of mitochondrial ATP synthesis in parkin overexpressing
cells could keep pace with that of ATP translocation from mitochon-
dria to cytoplasm, thus making changes in mitochondrial ATP similar
to those measured in control cells.
Our results suggested that parkin is essential to maintain mito-
chondrial network integrity possibly by sustaining ER–mitochondria
connections and guaranteeing the proper ER–mitochondria Ca2+
transfer. Interestingly, we have obtained similar evidence also for
α-synuclein [63] and DJ-1 (unpublished data), suggesting that this
action may represent a common mechanism shared by different
PD-related proteins.
We have also found that, when this action was missing (i.e., in
parkin downregulated cells), the ER–mitochondria tethering was re-
duced, the agonist-stimulated Ca2+ entry in mitochondrial matrix
was compromised, and cells showed alterations of the mitochondrial
network, underlining that molecular mechanisms that coordinate the
interplay between ER and mitochondria are relevant to the control of
mitochondria integrity. Even if our study was limited to the analysis
of the ER–mitochondria Ca2+ transfer, which is only one of multiple
parameters that could be compromised by the impairment of ER–
mitochondrial tethering, our data on ATP are consistent with theﬁnding that mitochondria from parkin KO mice displayed reduced
mitochondrial respiratory activity and that signs of oxidative dam-
age have been detected in brains of KO mice [56] and in ﬁbroblast of
PD patients with parkin mutations [54,64].
The data presented here not only indicated that parkin is required
for guaranteeing ER–mitochondria contact sites, maintaining mito-
chondrial Ca2+ homeostasis and network integrity, but also that its
overexpression favored the ER–mitochondria connections and conse-
quently the ER–mitochondria Ca2+ transfer, thus enhancing ATP pro-
duction following cell stimulation. Parkin overexpression has been
shown to represent a strategic mechanism adopted by the cells to over-
come ER and mitochondrial stress [27], however it was not clear the
precise role of parkin in the communication between these two organ-
elles. The enhanced cytosolic ATP levels could in turn provide fuel to
aliment cell protective responses, and prolong cell survival.
The next step will be to ﬁgure out the precise mechanism of parkin
in mediating ER–mitochondria contact sites: suggestions come from
the ﬁnding that parkin, similarly to α-synuclein and DJ-1 [65], has
been shown to interact with grp75 (mortalin) and to rescue mitochon-
drial dysfunctions induced by its down regulation [66]. Since grp75 has
been demonstrated to couple InsP3 receptors with VDAC1, and in this
way regulate the mitochondria Ca2+ uptake machinery [67], the possi-
bility that parkin could act downstream grp75 must be considered. The
possible involvement of mitofusins is also intriguing, since mitofusin 2
has been demonstrated to tether ER tomitochondria [43]. Parkin medi-
ated mitofusin ubiquitination may provide a mechanism to label mito-
chondria destined to degradation by mitophagy but also act as ﬁrst
tentative of rescue by sustaining cellular bioenergetics through the en-
gagement of ER–mitochondria connections. Subcellular fractionation
experiments of parkin overexpressing cells indicated that, in our
overexpression conditions (and under basal conditions) overexpressed
parkin ismostly cytosolic. However, the detection of parkin signal in the
mitochondrial fraction, where Mfn2 and VDAC1 (two proteins of the
outer mitochondrial membrane that also participate to the formation
of the ER–mitochondria contact sites) were speciﬁcally detected,
may suggest a possible preferentially parkin localization near the
ER–mitochondria contact sites in respect to other cytosolic proteins,
as documented by the absence of α-tubulin in that fraction.
On the basis of these results, it could be proposed that parkin may
have a versatile role according to its localization that, in turn, depends
on the cell/mitochondria status. When mitochondria were severely
compromised (depolarized), parkin is selectively recruited to damaged
mitochondria and promotes their removal by mitophagy; when they
are still functional, parkin stays in the cytoplasm (and possibly near
the ER–mitochondria contact sites) and promotes mitochondria activi-
ties by regulating Ca2+ ﬂuxes enhancing ER–mitochondria coupling.
5. Conclusions
In summary, we have shown that parkin, by favoring ER–
mitochondria tethering, also favored Ca2+ transfer from the ER to mi-
tochondria, sustained organellemorphology andATP production.When
the protein is defective, ER–mitochondria contact sites are reduced,
Ca2+ uptake is impaired and mitochondria undergo massive fragmen-
tation. These data account for a role for parkin independent from itsmi-
tochondrial translocation, suggesting that it could exert its protective
role at two different levels. The ﬁrst level may be activated by mecha-
nisms that increase parkin expression, as documented by Bouman and
coworkers [27]. Here we propose that parkin overexpression could
compensate for possible mitochondria impairment by enhancing ATP
production thank to the ability to modulate ER–mitochondria Ca2+
transfer. This aspect is emerging as a key element in cell bioenergetics
as recently documented by studies showing that mitochondria elonga-
tion occurring during autophagy is determinant to increase ATPproduc-
tion and sustain cell viability [68]. The second level of defense is
activatedwhen this compensationwas not sufﬁcient, and cellular stress
507T. Calì et al. / Biochimica et Biophysica Acta 1832 (2013) 495–508is too extended to be counteracted: at this point the removal of dam-
aged mitochondria become necessary and inevitable to preserve the
healthy population, thus parkin is recruited to mitochondria and pro-
mote mitophagy according to a well-recognized pathway.Acknowledgements
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